Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q53252734)
Watch
English
Economics, pharmacoeconomics and drug discovery for dementias.
scientific article published in August 2002
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12546957
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/12546957
editorial
0 references
title
Economics, pharmacoeconomics and drug discovery for dementias.
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12546957
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/12546957
main subject
drug discovery
1 reference
based on heuristic
inferred from title
author name string
Howard Fillit
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12546957
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/12546957
publication date
1 August 2002
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12546957
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/12546957
published in
Drug Discovery Today
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12546957
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/12546957
volume
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12546957
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/12546957
issue
15
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12546957
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/12546957
page(s)
785-787
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12546957
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/12546957
cites work
The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preclinical and clinical challenges in the development of disease-modifying therapies for Alzheimer's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current progress on new therapies for Alzheimer's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidemiology of dementia and Alzheimer's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The US economic and social costs of Alzheimer's disease revisited
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estimated prevalence of Alzheimer's disease in the United States
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current concepts in mild cognitive impairment
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost of Alzheimer's disease and related dementia in managed-medicare.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How much do persons with Alzheimer's disease cost Medicare?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The relative effect of Alzheimer's disease and related dementias, disability, and comorbidities on cost of care for elderly persons
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Societal costs of vascular cognitive impairment in older adults.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The costs of vascular dementia: a comparison with Alzheimer's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Impact of the type and severity of dementia on hospitalization and survival of the elderly. The SAGE Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An economic evaluation of donepezil in the treatment of Alzheimer's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessment of health economics in Alzheimer's disease (AHEAD): galantamine treatment in Canada
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Barriers to drug discovery and development for Alzheimer disease.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1359-6446%2802%2902379-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1359-6446(02)02379-6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12546957
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/12546957
PubMed publication ID
12546957
1 reference
stated in
Europe PubMed Central
PubMed publication ID
12546957
retrieved
12 May 2018
reference URL
http://europepmc.org/abstract/MED/12546957
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit